Literature DB >> 8226809

Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells.

N Sakata1, X Wu, J L Dixon, H N Ginsberg.   

Abstract

Under lipid-poor conditions, most newly synthesized apolipoprotein B100 (apoB) undergoes rapid degradation in Hep G2 cells such that only a small fraction of newly synthesized apoB is actually secreted. Addition of oleate to Hep G2 culture medium stimulates apoB secretion by a post-translational mechanism. In the current studies we have explored oleate-stimulation of apoB secretion by using calpain inhibitor I, N-acetyl-leucyl-leucyl-norleucinal (ALLN), a compound that inhibits the intracellular degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and the T cell receptor alpha subunit. Preincubation of Hep G2 cells with ALLN (40 micrograms/ml) for 1 h markedly inhibited degradation of newly synthesized apoB. Whereas only 32% of newly labeled apoB remained intact (cells+medium) in control cells after a 10-min pulse with [3H]leucine followed by a 60-min chase, 84% of labeled apoB was intact in ALLN-treated cells. However, most of the ALLN-protected apoB remained intracellular, as ALLN did not stimulate the rate of apoB secretion over the control rate (12 versus 9.2%). Although secretion of apoB was not accelerated, the protection afforded by ALLN continued for several hours, and labeled apoB continued to be secreted over 3 h of chase after which secretion ceased. The protection afforded by ALLN resulted in 37% of labeled apoB secreted by 3 h compared to 15% in control cells. In contrast, simultaneous treatment of cells with ALLN and oleate both accelerated and increased total apoB secretion, such that 36% of initially labeled apoB was recovered in the medium by 60 min and 71% of labeled apoB was secreted by 180 min of chase. These data show that ALLN and oleate affect apoB metabolism by different mechanisms. Although ALLN can protect nascent apoB from rapid early intracellular degradation, it does not accelerate apoB secretion. In contrast, although our results can not rule out the possibility that oleate may directly inhibit proteolysis of apoB, oleate appears to protect apoB mainly by facilitating transport of apoB out of a protease-containing compartment associated with the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226809

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway.

Authors:  Eric A Fisher; Neeraj A Khanna; Roger S McLeod
Journal:  J Lipid Res       Date:  2011-03-18       Impact factor: 5.922

Review 2.  The biogenesis of chylomicrons.

Authors:  Charles M Mansbach; Shadab A Siddiqi
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

Review 3.  Intestinal CD36 and Other Key Proteins of Lipid Utilization: Role in Absorption and Gut Homeostasis.

Authors:  Vincenza Cifarelli; Nada A Abumrad
Journal:  Compr Physiol       Date:  2018-03-26       Impact factor: 9.090

4.  Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin.

Authors:  N M Borradaile; K K Carroll; E M Kurowska
Journal:  Lipids       Date:  1999-06       Impact factor: 1.880

5.  Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.

Authors:  M A Robin; M Maratrat; M Le Roy; F P Le Breton; E Bonierbale; P Dansette; F Ballet; D Mansuy; D Pessayre
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

6.  Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice.

Authors:  Seongah Han; Chien-Ping Liang; Marit Westerterp; Takafumi Senokuchi; Carrie L Welch; Qizhi Wang; Michihiro Matsumoto; Domenico Accili; Alan R Tall
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

7.  Modulation of HepG2 cell net apolipoprotein B secretion by the citrus polymethoxyflavone, tangeretin.

Authors:  Elzbieta M Kurowska; John A Manthey; Adele Casaschi; Andre G Theriault
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

8.  Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents.

Authors:  Tsuguhito Ota; Constance Gayet; Henry N Ginsberg
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms.

Authors:  D Neumann; M H Yuk; H F Lodish; G Z Lederkremer
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

10.  Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes.

Authors:  J D Sparks; T L Phung; M Bolognino; C E Sparks
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.